Acquisition Agreement with Boehringer Ingelheim for NBE-Therapeutics Marks First Major Biotech Exit for PPF Group

NEXT STORY
TRACON Pharmaceuticals Announces Dosing of First Patient in ENVASARC Pivotal Trial
PREV STORY
Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sensus Healthcare Announces the Sale/Install of its 500th Unit

author_avatar
NASDAQ Market News

New interim phase IIa data on simeprevir in combination with other DAAs will be presented at the upcoming EASL AASLD Special Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new clinical data ...

author_avatar
NASDAQ Market News

MPI – Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients – Collaborative LiPlaCis Regulatory Meeting with DKMA

Oncology Venture Provides Clinical and Business Update Hoersholm, Denmark, July 2, 2018 -Medical Prognosis ...

author_avatar
NASDAQ Market News